Zeba N. Singh
- Hematology top 2%
- Oncology top 5%
- Molecular Biology
- Immunology
- Genetics top 10%
- Co-authors
- Frits van RheeAshraf BadrosBart BarlogieSusann SzmaniaKatie StoneAaron P. RapoportMehmet H. KocogluCameron Dell
- Topics
- Multiple Myeloma Research and Treatments (15 papers)Acute Myeloid Leukemia Research (13 papers)Protein Degradation and Inhibitors (8 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesIndia
In The Last Decade
Zeba N. Singh
48 papers receiving 966 citations
Peers
Comparison fields: 5 of 74
- Hematology 497
- Oncology 485
- Molecular Biology 360
- Immunology 182
- Genetics 130
Countries citing papers authored by Zeba N. Singh
This map shows the geographic impact of Zeba N. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeba N. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeba N. Singh more than expected).
Fields of papers citing papers by Zeba N. Singh
This network shows the impact of papers produced by Zeba N. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeba N. Singh. The network helps show where Zeba N. Singh may publish in the future.
Co-authorship network of co-authors of Zeba N. Singh
This figure shows the co-authorship network connecting the top 25 collaborators of Zeba N. Singh. A scholar is included among the top collaborators of Zeba N. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeba N. Singh. Zeba N. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 14 | |
| 8 | 5 | |
| 9 | 146 | |
| 10 | 0 | |
| 11 | 6 | |
| 12 | 144 | |
| 13 | 20 | |
| 14 | 1 | |
| 15 | 45 | |
| 16 | 6 | |
| 17 | 33 | |
| 18 | 7 | |
| 19 | Primary gastric tuberculosis. | 1 |
| 20 | Evaluation of bacteria and biliary tract diseases. | 1 |
About Zeba N. Singh
Zeba N. Singh is a scholar working on Hematology, Genetics and Oncology, having authored 54 papers that have together received 984 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Acute Myeloid Leukemia Research (13 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Hematology (497 citations), Oncology (485 citations) and Genetics (130 citations). Zeba N. Singh has collaborated with scholars based in United States and India. Frequent co-authors include Frits van Rhee, Ashraf Badros, Bart Barlogie, Susann Szmania, Katie Stone, Aaron P. Rapoport, Mehmet H. Kocoglu, Cameron Dell, Olga Goloubeva and Maria R. Baer. Their work appears in journals such as Blood, Cancer Cell and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.